Premium
EXACERBATION RISK DOES NOT INCREASE FOLLOWING SWITCH FROM LABA/ICS TO INDACATEROL/GLYCOPYRRONIUM (IND/GLY) IN PATIENTS WITH COPD: THE DACCORD REAL LIFE STUDY
Publication year - 2017
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13207_245
Subject(s) - indacaterol , medicine , exacerbation , copd exacerbation , citation , copd , library science , lung , lung function , computer science , acute exacerbation of chronic obstructive pulmonary disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom